SAMDaily.us | SRCSGT | H | Using Transgenic Mouse to Generate Human Antibodies

SAMDAILY.US - ISSUE OF MARCH 10, 2022 SAM #7405
SOURCES SOUGHT

H -- Using Transgenic Mouse to Generate Human Antibodies

Notice Date: 3/8/2022 3:17:24 PM
Notice Type: Sources Sought
Contracting Office: CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
ZIP Code: 30333
Solicitation Number: RFI-62675
Response Due: 3/18/2022 2:00:00 PM
Point of Contact: Joseph Gugumuck, Phone: 7037127645
E-Mail Address: qna4@cdc.gov
(qna4@cdc.gov)
Small Business Set-Aside: SBA Total Small Business Set-Aside (FAR 19.5)
Description: CDC seeks to test a transgenic mouse model that is engineered with human immunoglobulin gene segments to produce humanized antibodies, with the goal of determining if the antibodies generated from that mouse model can better recapitulate the antibody repertoire from humans. �� Overall objective is to provide the Influenza Division with transgenic mice that express human antibody repertoire, which would be useful for assessing the efficacy of Candidate Vaccine Viruses (CVVs) and developing antibodies.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/5f62876231e94765b7220a4cb57f8084/view)
Place of Performance: Address: Atlanta, GA 30341, USA; Zip Code: 30341; Country: USA
Record: SN06261002-F 20220310/220308230106 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |